ADVM vs. URGN
ADVM (Adverum Biotechnologies, Inc.) and URGN (UroGen Pharma Ltd.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, ADVM returned -33.53%/yr vs 8.15%/yr for URGN. At a 0.25 correlation, their price movements are largely independent.
Performance
ADVM vs. URGN - Performance Comparison
Loading charts...
Returns By Period
ADVM
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- 0.00%
- 6M
- 4.56%
- 1Y
- 73.71%
- 3Y*
- -28.84%
- 5Y*
- -33.53%
- 10Y*
- -20.75%
URGN
- 1D
- 0.23%
- 1M
- 14.21%
- YTD
- 13.58%
- 6M
- 9.24%
- 1Y
- 432.00%
- 3Y*
- 39.78%
- 5Y*
- 8.15%
- 10Y*
- —
ADVM vs. URGN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ADVM Adverum Biotechnologies, Inc. | 0.00% | -6.64% | -37.96% | 29.91% | -67.07% | -83.76% | -5.90% | 265.71% | -10.00% | 22.81% |
URGN UroGen Pharma Ltd. | 13.58% | 119.91% | -29.00% | 69.11% | -6.73% | -47.23% | -46.00% | -22.50% | 15.72% | 166.17% |
Correlation
The correlation between ADVM and URGN is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.08 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.23 |
Correlation (All Time) Calculated using the full available price history since May 5, 2017 | 0.25 |
The correlation between ADVM and URGN shifts across timeframes, from 0.08 (1 year) to 0.25 (all time), reflecting how their relationship changes across market environments.
Fundamentals
ADVM:
$102.40M
URGN:
$1.33B
ADVM:
-$9.19
URGN:
-$2.73
ADVM:
$0.00
URGN:
$140.49M
ADVM:
-$465.00K
URGN:
$126.24M
ADVM:
-$205.45M
URGN:
-$117.04M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ADVM vs. URGN — Risk / Return Rank
ADVM
URGN
ADVM vs. URGN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Adverum Biotechnologies, Inc. (ADVM) and UroGen Pharma Ltd. (URGN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ADVM | URGN | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.07 | ||
| Sortino ratioReturn per unit of downside risk | -2.60 | ||
| Omega ratioGain probability vs. loss probability | 1.36 | 1.59 | -0.23 |
| Calmar ratioReturn relative to maximum drawdown | 3.40 | 10.32 | -6.91 |
| Martin ratioReturn relative to average drawdown | 5.48 | 21.43 | -15.95 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ADVM | URGN | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.38 | 4.45 | -3.07 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.45 | 0.09 | -0.54 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.26 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.31 | 0.09 | -0.41 |
Drawdowns
ADVM vs. URGN - Drawdown Comparison
The maximum ADVM drawdown since its inception was -99.20%, which is greater than URGN's maximum drawdown of -93.98%. Use the drawdown chart below to compare losses from any high point for ADVM and URGN.
Loading charts...
Drawdown Indicators
| ADVM | URGN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.20% | -93.98% | -5.22% |
Max Drawdown (1Y)Largest decline over 1 year | -27.61% | -42.22% | +14.61% |
Max Drawdown (3Y)Largest decline over 3 years | -92.70% | -82.64% | -10.06% |
Max Drawdown (5Y)Largest decline over 5 years | -94.63% | -82.64% | -11.99% |
Max Drawdown (10Y)Largest decline over 10 years | -99.20% | — | — |
Current DrawdownCurrent decline from peak | -98.30% | -59.28% | -39.02% |
Average DrawdownAverage peak-to-trough decline | -69.72% | -61.55% | -8.17% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 25.54% | 20.28% | +5.26% |
Volatility
ADVM vs. URGN - Volatility Comparison
The current volatility for Adverum Biotechnologies, Inc. (ADVM) is 0.00%, while UroGen Pharma Ltd. (URGN) has a volatility of 20.26%. This indicates that ADVM experiences smaller price fluctuations and is considered to be less risky than URGN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ADVM | URGN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 0.00% | 20.26% | -20.26% |
Volatility (6M)Calculated over the trailing 6-month period | 26.29% | 46.53% | -20.24% |
Volatility (1Y)Calculated over the trailing 1-year period | 68.06% | 97.85% | -29.79% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 76.85% | 91.53% | -14.68% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 81.33% | 79.56% | +1.77% |
Dividends
ADVM vs. URGN - Dividend Comparison
Neither ADVM nor URGN has paid dividends to shareholders.
Financials
ADVM vs. URGN - Financials Comparison
This section allows you to compare key financial metrics between Adverum Biotechnologies, Inc. and UroGen Pharma Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ADVM and URGN have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
URGN has higher volatility (20.26%) compared to ADVM (0.00%). In terms of maximum drawdown, ADVM dropped -99.20% vs URGN's -93.98%.
URGN currently has the higher Sharpe Ratio (4.45 vs 1.38), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ADVM and URGN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer